14.26
price up icon0.64%   0.09
after-market After Hours: 14.26
loading
Surgery Partners Inc stock is traded at $14.26, with a volume of 1.11M. It is up +0.64% in the last 24 hours and down -8.88% over the past month. Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.
See More
Previous Close:
$14.17
Open:
$14.17
24h Volume:
1.11M
Relative Volume:
0.61
Market Cap:
$1.87B
Revenue:
$3.34B
Net Income/Loss:
$97.10M
P/E Ratio:
-23.97
EPS:
-0.595
Net Cash Flow:
$208.00M
1W Performance:
+4.16%
1M Performance:
-8.88%
6M Performance:
+1.28%
1Y Performance:
-36.23%
1-Day Range:
Value
$14.06
$14.51
1-Week Range:
Value
$13.18
$15.08
52-Week Range:
Value
$11.41
$23.44

Surgery Partners Inc Stock (SGRY) Company Profile

Name
Name
Surgery Partners Inc
Name
Phone
615-234-5900
Name
Address
340 SEVEN SPRINGS WAY, BRENTWOOD, TN
Name
Employee
16,000
Name
Next Earnings Date
2026-08-04
Name
Latest SEC Filings
Name
SGRY's Discussions on Twitter

Compare SGRY vs HCA, THC, FMS, EHC, DVA

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
SGRY icon
SGRY
Surgery Partners Inc
14.26 1.83B 3.34B 97.10M 208.00M -0.595
HCA icon
HCA
Hca Healthcare Inc
405.00 87.96B 76.39B 7.81B 7.93B 29.08
THC icon
THC
Tenet Healthcare Corp
265.05 21.95B 21.46B 2.65B 3.35B 19.23
FMS icon
FMS
Fresenius Medical Care Ag Adr
22.66 12.47B 22.44B 1.35B 2.03B 1.9002
EHC icon
EHC
Encompass Health Corp
121.79 11.93B 6.07B 793.80M 464.40M 5.9914
DVA icon
DVA
Davita Inc
183.99 11.18B 13.84B 1.10B 1.49B 10.42

Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-18-25 Resumed JP Morgan Neutral
Jul-28-25 Resumed BofA Securities Buy
Dec-16-24 Initiated BofA Securities Buy
Oct-14-24 Initiated UBS Buy
Oct-11-24 Initiated KeyBanc Capital Markets Sector Weight
Jun-28-24 Initiated Macquarie Outperform
Mar-06-24 Initiated Barclays Equal Weight
Nov-14-23 Upgrade TD Cowen Market Perform → Outperform
Jun-02-23 Upgrade BofA Securities Neutral → Buy
May-12-23 Initiated Mizuho Buy
Apr-21-23 Initiated Cantor Fitzgerald Overweight
Nov-23-22 Reiterated RBC Capital Mkts Outperform
Jun-15-22 Downgrade BofA Securities Buy → Neutral
Jan-10-22 Resumed Citigroup Buy
Nov-30-21 Initiated Barclays Overweight
Nov-29-21 Upgrade Stifel Hold → Buy
Nov-01-21 Initiated JP Morgan Neutral
Oct-18-21 Initiated SVB Leerink Outperform
Sep-10-21 Initiated Cowen Market Perform
Jun-23-21 Resumed Stifel Hold
Sep-17-20 Reiterated The Benchmark Company Buy
Apr-27-20 Upgrade The Benchmark Company Hold → Buy
Mar-03-20 Downgrade The Benchmark Company Buy → Hold
Jan-14-20 Reiterated The Benchmark Company Buy
Nov-16-18 Initiated UBS Neutral
Sep-18-18 Upgrade BofA/Merrill Neutral → Buy
Jun-28-18 Upgrade Stifel Sell → Hold
Jan-30-18 Reiterated The Benchmark Company Buy
Nov-01-17 Downgrade BofA/Merrill Buy → Neutral
Aug-09-17 Downgrade KeyBanc Capital Mkts Overweight → Sector Weight
Aug-09-17 Downgrade Raymond James Strong Buy → Mkt Perform
Aug-09-17 Downgrade Stifel Hold → Sell
Apr-24-17 Reiterated Stifel Hold
Mar-10-17 Downgrade Stifel Buy → Hold
Jan-31-17 Initiated The Benchmark Company Buy
Jun-10-16 Initiated KeyBanc Capital Mkts Overweight
Mar-14-16 Reiterated RBC Capital Mkts Outperform
Oct-27-15 Initiated Stifel Buy
Oct-26-15 Initiated RBC Capital Mkts Outperform
Oct-26-15 Initiated Raymond James Strong Buy
View All

Surgery Partners Inc Stock (SGRY) Latest News

pulisher
Sep 03, 2026

Surgery Partners Director Teresa DeLuca Buys 11,250 Shares - Yahoo Finance

Sep 03, 2026
pulisher
Sep 02, 2026

Surgery Partners Inc (SGRY) Stock Down 4.2% -- Now Undervalued? GF Score: 61/100 - GuruFocus

Sep 02, 2026
pulisher
Sep 02, 2026

How Surgery Partners Inc. (SGRY) Affects Rotational Strategy Timing - Stock Traders Daily

Sep 02, 2026
pulisher
Sep 02, 2026

Surgery Partners stock gains as investors digest recent rally - AD HOC NEWS

Sep 02, 2026
pulisher
Sep 01, 2026

Surgery Partners stock holds gains as investors await next earnings update - AD HOC NEWS

Sep 01, 2026
pulisher
Aug 28, 2026

Barclays Maintains Surgery Partners(SGRY.US) With Hold Rating, Maintains Target Price $14 - Moomoo

Aug 28, 2026
pulisher
Aug 24, 2026

How Mixed Q2 Results and Slower M&A At Surgery Partners (SGRY) Have Changed Its Investment Story - simplywall.st

Aug 24, 2026
pulisher
Aug 21, 2026

Surgery Partners Inc (SGRY) Stock Up 4.2% and Still Undervalued -- GF Score: 63/100 - GuruFocus

Aug 21, 2026
pulisher
Aug 21, 2026

Surgery Partners director Teresa DeLuca buys $161,212 in stock By Investing.com - Investing.com Nigeria

Aug 21, 2026
pulisher
Aug 20, 2026

Surgery (SGRY) EPS and Revenue: EPS Lands Above Forecast; After Earnings: Shares Move Higher 2.50% on the DayEarnings Stability Report - Vinanet

Aug 20, 2026
pulisher
Aug 20, 2026

Surgery Partners director Teresa DeLuca buys $161,212 in stock - Investing.com

Aug 20, 2026
pulisher
Aug 20, 2026

Surgery Partners (SGRY) Insider Teresa Deluca Purchases 10,000 S - GuruFocus

Aug 20, 2026
pulisher
Aug 19, 2026

Surgery Partners (SGRY) Stock May Be Undervalued After Q2 Earnings Beat - Yahoo Finance

Aug 19, 2026
pulisher
Aug 19, 2026

Surgery Partners Director Teresa DeLuca Acquires 10,000 Shares at $14.35 Each - Kalkine Media

Aug 19, 2026
pulisher
Aug 18, 2026

Surgery Partners Earnings Call Highlights Strategic Reset - TipRanks

Aug 18, 2026
pulisher
Aug 18, 2026

Does Surgery Partners’ (SGRY) Slower M&A Pace Clarify or Complicate Its ASC-Focused Strategy? - Sahm

Aug 18, 2026
pulisher
Aug 17, 2026

Surgery Partners Beats Q2 Estimates, Divests Idaho Falls Hospitals in Strategic Pivot - finance.biggo.com

Aug 17, 2026
pulisher
Aug 17, 2026

Surgery Partners (SGRY) Q2 2026 Earnings Call Transcript - The Globe and Mail

Aug 17, 2026
pulisher
Aug 17, 2026

Community Health Trades at a Deep Discount to Peers: Hold or Fold? - TradingView

Aug 17, 2026
pulisher
Aug 17, 2026

The Top 5 Analyst Questions From Surgery Partners’s Q2 Earnings Call - Yahoo Finance

Aug 17, 2026
pulisher
Aug 15, 2026

Surgery Partners (SGRY) Reaffirmed Guidance On Revenue Growth, Is It Still A Bargain? - Sahm

Aug 15, 2026
pulisher
Aug 15, 2026

Outpatient & Specialty Care Stocks Q2 Highlights: Surgery Partners (NASDAQ:SGRY) - Yahoo Finance

Aug 15, 2026
pulisher
Aug 15, 2026

RBC Capital Adjusts Price Target on Surgery Partners to $19 From $20, Keeps Outperform Rating - Moomoo

Aug 15, 2026
pulisher
Aug 14, 2026

Surgery Partners Inc. (SGRY) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks

Aug 14, 2026
pulisher
Aug 14, 2026

King Street Capital discloses 4.6% Surgery Partners (SGRY) holding in Schedule 13G - Stock Titan

Aug 14, 2026
pulisher
Aug 12, 2026

Why (SGRY) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Aug 12, 2026
pulisher
Aug 12, 2026

Surgery Partners Inc (1SP.DU) Recent Insider Transactions - Yahoo! Finance Canada

Aug 12, 2026
pulisher
Aug 12, 2026

TD Cowen Initiates Surgery Partners(SGRY.US) With Buy Rating, Announces Target Price $19 - Moomoo

Aug 12, 2026
pulisher
Aug 12, 2026

Surgery Partners (NASDAQ:SGRY) Downgraded by Zacks Research to Hold - MarketBeat

Aug 12, 2026
pulisher
Aug 12, 2026

Surgery Partners (SGRY) Stock Drops As Idaho Falls Sale Reshapes Debt Story - Sahm

Aug 12, 2026
pulisher
Aug 12, 2026

Surgery Partners Inc (1SP.DU) insider ownership and holdings - Yahoo Finance UK

Aug 12, 2026
pulisher
Aug 11, 2026

Is Surgery Partners Inc (SGRY) a Bargain After 5.8% Drop? GF Val - GuruFocus

Aug 11, 2026
pulisher
Aug 11, 2026

Surgery Partners beats Q2 revenue and EPS estimates, with strong growth and positive outlook. - Pluang

Aug 11, 2026
pulisher
Aug 11, 2026

SGRY Maintained by TD Cowen -- Price Target Raised to $19.00 - GuruFocus

Aug 11, 2026
pulisher
Aug 11, 2026

Cantor Fitzgerald reiterates Surgery Partners stock rating at Overweight By Investing.com - Investing.com Nigeria

Aug 11, 2026
pulisher
Aug 11, 2026

SGRY Maintained by RBC Capital -- Price Target Lowered to $19.00 - GuruFocus

Aug 11, 2026
pulisher
Aug 11, 2026

Cantor Fitzgerald reiterates Surgery Partners stock rating at Overweight - Investing.com

Aug 11, 2026
pulisher
Aug 11, 2026

Benchmark reiterates Buy rating on Surgery Partners stock at $24 By Investing.com - Investing.com South Africa

Aug 11, 2026
pulisher
Aug 11, 2026

Benchmark reiterates Buy rating on Surgery Partners stock at $24 - Investing.com

Aug 11, 2026
pulisher
Aug 11, 2026

SGRY Reiterated by Cantor Fitzgerald -- Price Target Maintained at $18 - GuruFocus

Aug 11, 2026
pulisher
Aug 11, 2026

Surgery Partners (NASDAQ:SGRY) Given Overweight Rating at Cantor Fitzgerald - MarketBeat

Aug 11, 2026
pulisher
Aug 11, 2026

Surgery Partners (SGRY) Q2 Earnings: What To Expect - Yahoo Finance

Aug 11, 2026
pulisher
Aug 11, 2026

Surgery Partners, Inc. (SGRY) Investor Outlook: Navigating a 16.84% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews

Aug 11, 2026
pulisher
Aug 11, 2026

Surgery Partners Q2 2026 slides show 5% revenue growth, Idaho exit - Investing.com Canada

Aug 11, 2026
pulisher
Aug 11, 2026

SGRY Q2 Deep Dive: Portfolio Optimization and Acuity Mix Lead Operating Shift - The Globe and Mail

Aug 11, 2026
pulisher
Aug 10, 2026

Surgery Partners, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:SGRY) 2026-08-10 - Seeking Alpha

Aug 10, 2026
pulisher
Aug 10, 2026

Why Surgery Partners (NASDAQ:SGRY) Draws Healthcare Attention Monday? - Kalkine Media

Aug 10, 2026
pulisher
Aug 10, 2026

Surgery Partners (NASDAQ: SGRY) posts Q2 2026 loss and plans $795M hospital sale - Stock Titan

Aug 10, 2026
pulisher
Aug 10, 2026

Surgery Partners Crushes Q2 2026 Profit Estimates by 66.7% - AlphaStreet

Aug 10, 2026
pulisher
Aug 10, 2026

Surgery Partners: Q2 Earnings Snapshot - AOL.com

Aug 10, 2026
pulisher
Aug 10, 2026

Surgery Partners Releases Q2 2026 Financial Results - AlphaStreet

Aug 10, 2026

Surgery Partners Inc Stock (SGRY) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$12.73
price down icon 0.78%
$42.50
price down icon 1.32%
CHE CHE
$519.84
price down icon 0.88%
$170.79
price down icon 0.76%
UHS UHS
$169.65
price up icon 0.26%
DVA DVA
$183.99
price up icon 1.28%
Cap:     |  Volume (24h):